Edwards EVOQUE Eos MISCEND Study
Edwards Lifesciences
Edwards Lifesciences
National Cancer Institute (NCI)
St. Justine's Hospital
Actuate Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
Pfizer
Dana-Farber Cancer Institute
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
OncoNano Medicine, Inc.
Turning Point Therapeutics, Inc.
Case Comprehensive Cancer Center
Massive Bio, Inc.
M.D. Anderson Cancer Center
Cook Group Incorporated
Nurix Therapeutics, Inc.
ALX Oncology Inc.
Antengene Corporation
IGM Biosciences, Inc.
Cedars-Sinai Medical Center
BPGbio
National Cancer Institute (NCI)
Vector Vitale LLC
National Cancer Institute (NCI)
Tyligand Bioscience (Shanghai) Limited
Cedars-Sinai Medical Center
Synlogic
Cancer Support Community, Research and Training Institute, Philadelphia
OHSU Knight Cancer Institute
TopAlliance Biosciences
Rutgers, The State University of New Jersey
University of Colorado, Boulder
Innovent Biologics (Suzhou) Co. Ltd.
Chinese PLA General Hospital
Shanghai Henlius Biotech
Symphogen A/S
Seagen Inc.
Memorial Sloan Kettering Cancer Center
Weprom
Eli Lilly and Company
Symphogen A/S
Celgene
Menarini Group
Northwestern University
Chinese PLA General Hospital
Amgen
Symphogen A/S